sur INTRASENSE (EPA:ALINS)
Intrasense Announces Board of Directors Change
Intrasense, a French company specializing in AI-enhanced medical imaging solutions, has announced a change in its Board of Directors. On May 21, 2025, the board accepted the resignation of Mrs. Michèle Lesieur and appointed Mr. Steven F. Tolle as her successor. This change took effect on May 23, 2025, and will be up for ratification at the shareholders' meeting on June 25, 2025.
Mr. Tolle brings over 30 years of experience in healthcare, having worked in medical technologies, AI, and digital health. He currently holds the position of Chief Product & Technology Officer at IgniteData and has held significant roles at IBM Watson Health and Merge Healthcare.
Intrasense's Board of Directors now comprises six members, including the newly appointed Mr. Tolle, indicating the company's commitment to integrating expertise in digital health innovations.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de INTRASENSE